Panbela Therapeutics's total assets for Q3 2024 were $5.17M, a decrease of -45.10% from the previous quarter. PBLA total liabilities were $23.34M for the fiscal quarter, a 16.79% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.